Protocol Ledger

NCT04024137 · Phase II · COMPLETED

Study of ZSP1273 in Patients With Acute Uncomplicated Influenza A

Interventional Phase II clinical trial protocol NCT04024137 sponsored by Guangdong Raynovent Biotech Co in Infectious Disease and Vaccines, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2019-12-07 Enrollment: 172 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04024137
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)172 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04024137
Protocol FieldVerified Registry Value
NCT IdentifierNCT04024137
Consolidated Lead SponsorGuangdong Raynovent Biotech Co
Therapeutic Condition CohortInfectious Disease and Vaccines
Clinical Trial PhasePhase II
Overall Recruitment StatusCOMPLETED
Registered Enrollment172 participants (ACTUAL)
Registered Start Date2019-12-07
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Infectious Disease and Vaccines Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI